clofibrate has been researched along with Hypertriglyceridemia in 19 studies
angiokapsul: contains clofibrate & insoitolnicotinate
Hypertriglyceridemia: A condition of elevated levels of TRIGLYCERIDES in the blood.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A patient developed severe hypertriglyceridemia while on treatment with Tamoxifen after a mastectomy and with a statin for a lipid disorder." | 7.70 | Tamoxifen and hypertriglyceridemia. ( Jonkers, GH, 1999) |
| "In a pilot study the therapeutic effect of 2 x 500 mg etofibrate (Lipo Merz retard) on lipids and lipoproteins, fibrinolytic activity and clinical parameters was studied for four weeks in hyperlipidemic patients suffering from arteriosclerosis obliterans (Fontaine stage II/III)." | 7.67 | [Effectiveness of etofibrate in arteriosclerosis obliterans. Pilot study in hyperlipidemic patients with arteriosclerosis obliterans]. ( Basista, M; Bieroń, K; Czarnecka, H; Dembińska-Kieć, A; Grodzińska, L; Kedzior, A; Kostka-Trabka, E; Slawiński, M; Trabka, E; Zmuda, A, 1989) |
| "Clofibrate treatment improved TG metabolism and the histological and clinical findings in the psoriatic lesion." | 5.28 | [Clofibrate treatment of psoriasis with hypertriglycemia--clinical, histological and laboratory analysis]. ( Asagami, C; Imamura, T; Matsutani, Y; Ogasawara, M; Takata, I; Yamamoto, T, 1991) |
| "A patient developed severe hypertriglyceridemia while on treatment with Tamoxifen after a mastectomy and with a statin for a lipid disorder." | 3.70 | Tamoxifen and hypertriglyceridemia. ( Jonkers, GH, 1999) |
| "In a pilot study the therapeutic effect of 2 x 500 mg etofibrate (Lipo Merz retard) on lipids and lipoproteins, fibrinolytic activity and clinical parameters was studied for four weeks in hyperlipidemic patients suffering from arteriosclerosis obliterans (Fontaine stage II/III)." | 3.67 | [Effectiveness of etofibrate in arteriosclerosis obliterans. Pilot study in hyperlipidemic patients with arteriosclerosis obliterans]. ( Basista, M; Bieroń, K; Czarnecka, H; Dembińska-Kieć, A; Grodzińska, L; Kedzior, A; Kostka-Trabka, E; Slawiński, M; Trabka, E; Zmuda, A, 1989) |
| "Hypertriglyceridemia has been recently recognized as a vascular risk factor, based on both clinical and experimental findings." | 2.38 | Pharmacological control of hypertriglyceridemia. ( Franceschini, G; Paoletti, R, 1993) |
| "Clofibrate treatment resulted in a lighter LDL subfraction pattern (LDL1-LDL4)." | 1.29 | Identification of multiple dense LDL subfractions with enhanced susceptibility to in vitro oxidation among hypertriglyceridemic subjects. Normalization after clofibrate treatment. ( de Graaf, J; Demacker, PN; Hendriks, JC; Stalenhoef, AF, 1993) |
| "Clofibrate treatment improved TG metabolism and the histological and clinical findings in the psoriatic lesion." | 1.28 | [Clofibrate treatment of psoriasis with hypertriglycemia--clinical, histological and laboratory analysis]. ( Asagami, C; Imamura, T; Matsutani, Y; Ogasawara, M; Takata, I; Yamamoto, T, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (15.79) | 18.7374 |
| 1990's | 13 (68.42) | 18.2507 |
| 2000's | 2 (10.53) | 29.6817 |
| 2010's | 1 (5.26) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, D | 1 |
| Liu, B | 1 |
| Tao, W | 1 |
| Hao, Z | 1 |
| Liu, M | 1 |
| Chien, KL | 1 |
| Lin, YL | 1 |
| Wen, HC | 1 |
| Lin, HP | 1 |
| Yen, CT | 1 |
| Lin, SW | 1 |
| Kao, JT | 1 |
| FELT, V | 1 |
| STARKA, L | 1 |
| BEDNAR, J | 1 |
| Dobordzhginidze, LM | 1 |
| Gratsianskiĭ, NA | 1 |
| Wong, SS | 1 |
| Stuyt, PM | 1 |
| Stalenhoef, AF | 2 |
| Skrha, J | 1 |
| Sindelka, G | 1 |
| Haas, T | 1 |
| Hilgertová, J | 1 |
| Justová, V | 1 |
| Rodrigues, B | 1 |
| Grassby, PF | 1 |
| Battell, ML | 1 |
| Lee, SY | 1 |
| McNeill, JH | 1 |
| Welborn, TA | 1 |
| Bays, H | 1 |
| Lansing, AM | 1 |
| Franceschini, G | 1 |
| Paoletti, R | 1 |
| de Graaf, J | 1 |
| Hendriks, JC | 1 |
| Demacker, PN | 1 |
| Auwerx, J | 1 |
| Schoonjans, K | 1 |
| Fruchart, JC | 1 |
| Staels, B | 1 |
| Jonkers, GH | 1 |
| Capurso, A | 1 |
| Magarian, GJ | 1 |
| Lucas, LM | 1 |
| Colley, C | 1 |
| Imamura, T | 1 |
| Takata, I | 1 |
| Ogasawara, M | 1 |
| Matsutani, Y | 1 |
| Yamamoto, T | 1 |
| Asagami, C | 1 |
| Nityanand, S | 1 |
| Srivastava, JS | 1 |
| Asthana, OP | 1 |
| Dembińska-Kieć, A | 1 |
| Kostka-Trabka, E | 1 |
| Grodzińska, L | 1 |
| Bieroń, K | 1 |
| Kedzior, A | 1 |
| Basista, M | 1 |
| Zmuda, A | 1 |
| Trabka, E | 1 |
| Slawiński, M | 1 |
| Czarnecka, H | 1 |
7 reviews available for clofibrate and Hypertriglyceridemia
| Article | Year |
|---|---|
Fibrates for secondary prevention of cardiovascular disease and stroke.
Topics: Adult; Aged; Aged, 80 and over; Anticholesteremic Agents; Bezafibrate; Cardiovascular Diseases; Caus | 2015 |
[Fibrates: mechanism of action, effect on levels of lipids and lipoproteins, risk of coronary events. Part 1. Clofibrate, gemfibrosil, besafibrate].
Topics: Bezafibrate; Clofibrate; Female; Gemfibrozil; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Li | 2004 |
Dyslipidaemia in non-insulin dependent diabetes: the need for a clinical intervention trial.
Topics: Cholesterol, HDL; Clinical Trials as Topic; Clofibrate; Coronary Disease; Diabetes Mellitus, Type 2; | 1994 |
Pharmacological control of hypertriglyceridemia.
Topics: Body Weight; Cardiovascular Diseases; Clofibrate; Exercise; Fatty Acids, Omega-3; Humans; Hypertrigl | 1993 |
Regulation of triglyceride metabolism by PPARs: fibrates and thiazolidinediones have distinct effects.
Topics: Animals; Clofibrate; Humans; Hypertriglyceridemia; Microbodies; Nuclear Proteins; Receptors, Cytopla | 1996 |
Drugs affecting triglycerides.
Topics: Benzhydryl Compounds; Clofibrate; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Niacin | 1991 |
Gemfibrozil-induced myopathy.
Topics: Clofibrate; Drug Therapy, Combination; Gemfibrozil; Humans; Hypertriglyceridemia; Lovastatin; Male; | 1991 |
1 trial available for clofibrate and Hypertriglyceridemia
| Article | Year |
|---|---|
Clinical trials with gugulipid. A new hypolipidaemic agent.
Topics: Adult; Cholesterol; Clinical Trials as Topic; Clofibrate; Commiphora; Double-Blind Method; Female; H | 1989 |
11 other studies available for clofibrate and Hypertriglyceridemia
| Article | Year |
|---|---|
Common sequence variant in lipoprotein lipase gene conferring triglyceride response to fibrate treatment.
Topics: Apolipoproteins; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Clofibrate; Female; Genetic Variat | 2009 |
[EFFECT OF DEHYDROEPIANDROSTERONE AND ATROMID ON SERUM LIPIDS IN PATIENTS WITH HYPERCHOLESTEREMIA OR HYPERTRIGLYCERIDEMIA].
Topics: Androsterone; Butyrates; Clofibrate; Dehydroepiandrosterone; Humans; Hypercholesterolemia; Hyperlipi | 1965 |
Stevens-Johnson syndrome induced by clofibrate.
Topics: Adult; Clofibrate; Deglutition Disorders; Follow-Up Studies; Humans; Hypertriglyceridemia; Male; Ste | 1994 |
[Triglycerides and atherosclerosis; treatment of hypertriglyceridemia].
Topics: Anticholesteremic Agents; Clofibrate; Humans; Hypertriglyceridemia | 1994 |
[Relation between hypertriacylglycerolemia and the action of insulin in type 2 diabetes mellitus].
Topics: Adult; Aged; Clofibrate; Diabetes Mellitus, Type 2; Female; Fenofibrate; Humans; Hypertriglyceridemi | 1994 |
Hypertriglyceridemia in experimental diabetes: relationship to cardiac dysfunction.
Topics: Animals; Antihypertensive Agents; Blood Glucose; Cholesterol; Clofibrate; Diabetes Mellitus, Experim | 1994 |
Fish oil (omega-3 fatty acids) in treatment of hypertriglyceridemia. A practical approach for the primary care physician.
Topics: Aged; Clofibrate; Drug Therapy, Combination; Fatty Acids, Omega-3; Female; Gemfibrozil; Humans; Hype | 1994 |
Identification of multiple dense LDL subfractions with enhanced susceptibility to in vitro oxidation among hypertriglyceridemic subjects. Normalization after clofibrate treatment.
Topics: Aged; Chemical Fractionation; Chemical Phenomena; Chemistry, Physical; Chromatography, High Pressure | 1993 |
Tamoxifen and hypertriglyceridemia.
Topics: Anticholesteremic Agents; Antineoplastic Agents, Hormonal; Atorvastatin; Breast Neoplasms; Clofibrat | 1999 |
[Clofibrate treatment of psoriasis with hypertriglycemia--clinical, histological and laboratory analysis].
Topics: Adult; Clofibrate; Fatty Acids; Humans; Hypertriglyceridemia; Lipids; Male; Psoriasis; Skin | 1991 |
[Effectiveness of etofibrate in arteriosclerosis obliterans. Pilot study in hyperlipidemic patients with arteriosclerosis obliterans].
Topics: Adult; Arteriosclerosis Obliterans; Cholesterol, HDL; Clofibrate; Clofibric Acid; Female; Humans; Hy | 1989 |